Log in
Enquire now
‌

US Patent 10085970 Use of amisulpride as an anti-emetic

Patent 10085970 was granted and assigned to Acacia Pharma on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Acacia Pharma
0
Current Assignee
‌
Acacia Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100859700
Patent Inventor Names
Julian Clive Gilbert0
Gabriel Fox0
Nicola Cooper0
Robert William Gristwood0
Date of Patent
October 2, 2018
0
Patent Application Number
157904810
Date Filed
October 23, 2017
0
Patent Citations Received
‌
US Patent 12005042 Rescue treatment of post operative nausea and vomiting
0
‌
US Patent 10525033 Use of amisulpride as an anti-emetic
Patent Primary Examiner
‌
James D. Anderson
0
Patent abstract

Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10085970 Use of amisulpride as an anti-emetic

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.